---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-25-000774"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T05:11:23.034134+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# TOI shareholders approve reverse stock split up to 1:40; re-elect all 8 directors

## Summary
- Reverse stock split approved at ratio between 1:5 and 1:40, board discretion within one year.
- All eight director nominees elected; Richard Barasch received 39.2M votes for, 654k withheld.
- Ratification of BDO USA as auditor for FY2025 approved with 61.2M for, 682k against.
- Turnout of 61.9M shares representing 81.7% of outstanding common stock.

## SEC filing metadata
- accession: 0001079973-25-000774
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000107997325000774/0001079973-25-000774-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000107997325000774/toi_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-25-000774
- JSON: https://secwatch.observer/filing/0001079973-25-000774.json
- Plain text: https://secwatch.observer/filing/0001079973-25-000774.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.